1. Bruni LAG, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S (2019) Human Papillomavirus and Related Diseases in China. Summary Report 17 June 2019. (Date Accessed). ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre)
2. Wang HQ, Zhao FH, Zhao Y (2019) Consensus of experts on immune prevention of cervical cancer and other human papillomavirus-related diseases. Chin J Prev Med 53:761–803
3. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88:63–73
4. Gynecologists ACoOa (2016) Cervical Cancer Screening and Prevention. Practice Bulletin No. 157. The American College of Obstetricians and Gynecologists WOMEN’S HEALTH CARE PHYSICIANS
5. Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FAR, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH (2015) Use of primary high-risk human papillomavirus testing for cervical cancer screening. Obstet Gynecol 125:330–337